Anders R Holmberg – founder and CEO
Anders R Holmberg is the founder and CEO of DexTech. Holmberg holds a doctorate in medicine from Uppsala University, and is a qualified chemical engineer. He specialises in chemical glycosylation, with over 30 years of experience including process development. He was employed at Pharmacia Corporation between 1978-1997. Holmberg was also Director of Development at MAP Medical Applied Products AB/Oy, 1999-2003, and CEO of MAP AB, 2001-2003. Anders R Holmberg has had around 50 scientific articles published.
Sten Nilsson – founder
Sten Nilsson, born 1948 is the founder of DexTech. Nilsson holds a Doctor of Medicine, PhD, professor in oncology. Nilsson is an internationally-acknowledged authority within urological oncology, especially prostate cancer. After over 30 years of clinical experience, he has access to an extensive international network. Nilsson is employed as professor and consultant at the Radiumhemmet hospital. Through his profession, Sten Nilsson has daily contact with the clinical reality of prostate patients. He also has extensive experience of clinical studies with new medications, as he has been involved in the design and execution of the Algeta/Bayer phase I, II and III studies for Alpharadin/Xofigo. Sten Nilsson has published around 200 scientific articles.